Header Logo

Connection

SUSAN BLANEY to Immunoconjugates

Back to Details
This is a "connection" page, showing publications SUSAN BLANEY has written about Immunoconjugates.
SUSAN BLANEY
Connection Strength
0.153
Immunoconjugates
  1. Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1-2 trial. Lancet Oncol. 2018 09; 19(9):1229-1238.
    View in: PubMed
    Score: 0.153
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.